Mazor Robotics' gross profit for the first quarter more than doubled from $1.9 million in 2012 to $4 million in the three month period ending March 31.

Wilmington, Mass.-based Accellent suffered a net loss of $62.1 million in the first quarter of 2013, compared to $7 million in 2012, due largely to a $51 million pre-tax goodwill impairment charge from changing the composition of segments and reporting units.

United Surgical Partners International's net income for the first quarter was $7.6 million, down 59.5% from the same time last year.

Lewisville, Texas-based Orthofix International's gross profits dipped in the first quarter, down 17 percent from 2012's first quarter due to substantial declines in spine and orthopedic implant sales.

London-based Smith & Nephew announced first quarter revenue at $1.075 billion, down nearly 4 percent from $1.079 billion reported during the same period last year.

Carlsbad, Calif.-based Alphatec Spine reported a $32.7 million gross profit in the first quarter, up 2.9 percent from the $31.8 million gross profit during the same period last year.

Here are financial report updates from 20 orthopedic and orthopedic-driven device companies for the first quarter of 2012 or the recently reported third quarter of the 2012 fiscal year. If you have comments or questions on this list, please contact Laura at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

Alphatec Holdings, the parent company of Alphatec Spine, which designs, develops, manufactures and markets products for the surgical treatment of spine disorders, announced its results for the quarter ended March 31, 2010, according to an Alphatec news release.

Osteotech, a leader in the emerging field of biologic products for regenerative healing, reported financial results for the first quarter ended March 31, 2010, which included the launch of the company's Plexur M Innovated Grafting and MagniFuse Bone Graft products, according to an Osteotech news release.

Warsaw, Ind.-based Symmetry Medical announced its results for the quarter ended April 3, 2010, which included a 10.6 percent gain on a sequential basis from the fourth quarter of 2009, according to a Symmetry news release.